[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  TMD - The Market Daily [@justtmd_com](/creator/twitter/justtmd_com) on x XXX followers Created: 2025-07-20 13:10:31 UTC GLP-1 Weight Loss Drugs Show Promise in Treating PCOS Symptoms Despite Lack of FDA Approval. GLP-1 drugs like Ozempic and Wegovy—originally for diabetes and weight loss—are showing promise in easing PCOS symptoms like weight gain, irregular periods, and insulin resistance. Though not FDA-approved for PCOS, early studies and patient reports point to improvements in hormone levels, acne, and menstrual regularity. Roughly XX% of women with PCOS have insulin resistance, and these meds help regulate blood sugar and appetite—key issues in PCOS management. But insurance rarely covers off-label use, and monthly costs can exceed $XXXXX without coverage. Despite limited research and ongoing shortages, momentum is growing. Researchers and users alike are pushing for further studies—and recognition—for these potential game-changers in PCOS care.  XX engagements  **Related Topics** [ozempic](/topic/ozempic) [weight loss](/topic/weight-loss) [Post Link](https://x.com/justtmd_com/status/1946920657096229047)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
TMD - The Market Daily @justtmd_com on x XXX followers
Created: 2025-07-20 13:10:31 UTC
GLP-1 Weight Loss Drugs Show Promise in Treating PCOS Symptoms Despite Lack of FDA Approval.
GLP-1 drugs like Ozempic and Wegovy—originally for diabetes and weight loss—are showing promise in easing PCOS symptoms like weight gain, irregular periods, and insulin resistance. Though not FDA-approved for PCOS, early studies and patient reports point to improvements in hormone levels, acne, and menstrual regularity.
Roughly XX% of women with PCOS have insulin resistance, and these meds help regulate blood sugar and appetite—key issues in PCOS management. But insurance rarely covers off-label use, and monthly costs can exceed $XXXXX without coverage.
Despite limited research and ongoing shortages, momentum is growing. Researchers and users alike are pushing for further studies—and recognition—for these potential game-changers in PCOS care.
XX engagements
Related Topics ozempic weight loss
/post/tweet::1946920657096229047